It’s hard enough to get a complete look at how much your plan is spending on specialty care, let alone how much you can save through a solution.
That’s why we’ve publicly released our TrueRate™ savings methodology. Now, benefitsleaders, consultants and any other stakeholders cansee exactly how we get to our numbers using our Validated Episode Pricing model—and how your team can analyze your own data for a clear understanding of your spending and how to lower it.
This report will empower you to:
Recognize and correct common issuesin your claims analysis like claims lag, incomplete dataand inconsistent episode definitions
Make more accurate, apples-to-apples cost comparisonsof specialty care solutions so you can choose the option that delivers the most savings
Ask vendors the right questions about how savings are calculated and challenge misleading or opaque methodologies
Advocate for transparency in our industry and encourage others to unlock access to their savings methodologies
Download Now
Industry Praise for Lantern's Savings Methodology
We have pushed for transparency across all health care services for a long time. Access to information about the price and quality of health care items, services and providers is critically important. The publication of Lantern's methodology is a big step forward in bringing transparency into bundled pricing and episodic costs.”
Ellen Kelsay
President & CEO, Business Group on Health
The analytical approach articulated by Lantern is the gold standard that I, as an academic researcher, push for. If more people who worked in the healthcare ecosystem followed a methodology like this, we would all be better for it.
Caitlin Hicks, MD
Vascular surgeon, Associate Professor of Surgery, Director, Johns Hopkins Center for Surgery Outcomes Research & Editor-in-Chief, Surgery
Benefits leaders have the incredible task of stewarding billions of health plan dollars. They deserve a consistent standard for how to calculate savings so they can measure impact and properly evaluate all their partners. Given an environment of elevated cost trend and fiduciary scrutiny, rationalizing solutions that cannot demonstrate value and doubling down on those that can—is critical.
Brian Marcotte
Immediate past president & CEO of the Business Group on Health
Healthcare is expensive and only getting worse, and that’s a real problem for employers, who are one of the biggest payers in our healthcare system. But the challenge, particularly in specialty careis that there isn’t really even agreement on the basics. There is no standard way to define an episode of care, for example. Lantern has taken on the herculean effort of exposing the areas where there is disagreement in calculating surgical care cost calculations, offering a new standard, and promoting a more transparent model.”
Zeke Emanuel, MD
Oncologist and global health policy leader; University of Pennsylvania Perelman School of Medicine
